Literature DB >> 15501620

Platelet function, coagulopathy, and impaired fibrinolysis in diabetes.

Burton E Sobel1, David J Schneider.   

Abstract

Diabetes and the metabolic syndrome, including insulin resistance, that underlies it are hyper-coagulable states. Increased platelet reactivity,augmented activity of the coagulation system,and impaired fibrinolysis are characteristic and understood to a remarkable extent. In aggregate,these derangements contribute to accelerated atherosclerosis, premature coronary artery dis-ease, and a profound toll from both.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501620     DOI: 10.1016/j.ccl.2004.06.009

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  17 in total

1.  Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia.

Authors:  Yi Ma; Mohammad Z Ashraf; Eugene A Podrez
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

2.  The mean platelet volume in gestational diabetes.

Authors:  Nuray Bozkurt; Ercan Yilmaz; Aydan Biri; Zeki Taner; Ozdemir Himmetoğlu
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

Review 3.  The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.

Authors:  Frederick Schatz; Ozlem Guzeloglu-Kayisli; Sefa Arlier; Umit A Kayisli; Charles J Lockwood
Journal:  Hum Reprod Update       Date:  2016-02-23       Impact factor: 15.610

4.  Is the Mean Platelet Volume a Predictive Marker of a Low Apgar Score and Insulin Resistance in Gestational Diabetes Mellitus? A Retrospective Case-Control Study.

Authors:  Levent Kebapcilar; Ayse Gul Kebapcilar; Tolgay Tuyan Ilhan; Suleyman Hilmi Ipekci; Suleyman Baldane; Aybike Pekin; Mustafa Kulaksizoglu; Cetin Celik
Journal:  J Clin Diagn Res       Date:  2016-10-01

5.  Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome.

Authors:  Ilaria Cavallari; Ernesto Maddaloni; Felice Gragnano; Giuseppe Patti; Emilia Antonucci; Paolo Calabrò; Plinio Cirillo; Paolo Gresele; Gualtiero Palareti; Vittorio Pengo; Pasquale Pignatelli; Rossella Marcucci
Journal:  Intern Emerg Med       Date:  2021-02-22       Impact factor: 3.397

6.  An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study.

Authors:  Chris E Holmes; Maria E Ramos-Nino; Benjamin Littenberg
Journal:  BMC Cancer       Date:  2010-06-15       Impact factor: 4.430

7.  Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.

Authors:  E Santini; S Madec; V Corretti; E Ferrannini; A Solini
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

8.  Transcriptional regulation of plasminogen activator inhibitor-1 in vascular endothelial cells induced by oxidized very low density lipoproteins.

Authors:  Ruozhi Zhao; Xiuli Ma; Garry X Shen
Journal:  Mol Cell Biochem       Date:  2008-07-03       Impact factor: 3.396

Review 9.  Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: an old dog with new tricks.

Authors:  Alexandra C Chadwick; Daisy Sahoo
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-04       Impact factor: 3.243

10.  Alcohol consumption and the risk of coronary heart disease in postmenopausal women with diabetes: Women's Health Initiative Observational Study.

Authors:  Swapnil N Rajpathak; Mathew S Freiberg; Cuiling Wang; Judith Wylie-Rosett; Rachel P Wildman; Thomas E Rohan; Jennifer G Robinson; Simin Liu; Sylvia Wassertheil-Smoller
Journal:  Eur J Nutr       Date:  2009-10-13       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.